Stock Price Forecast

March 3, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Sorrento Therapeutics Inc chart...

About the Company

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California.

CEO

Henry Ji

Exchange

NASDAQ

Website

https://sorrentotherapeutics.com/

$6M

Total Revenue

799

Employees

$148M

Market Capitalization

-0.26

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $SRNE News

SRNEQ Sorrento Therapeutics, Inc.

10d ago, source: Seeking Alpha

Sorrento Therapeutics, Inc., a clinical and commercial stage biopharmaceutical company, develops a portfolio of next-generation treatments for three therapeutic areas: cancer, infectious disease ...

Sorrento Therapeutics Inc SRNE

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Yuhan-Sorrento’s cancer-focused Immuneoncia targets Kosdaq IPO

2d ago, source: BioWorld

Immuneoncia Therapeutics Inc., a joint venture between South Korea’s Yuhan Corp. and San Diego-based Sorrento Therapeutics Inc., is looking to list on the Korea Exchange, having recently passed local ...

Sorrento Therapeutics Stock (OTC:SRNEQ), Quotes and News Summary

1y ago, source: Benzinga.com

Scilex Inks Distribution Agreement For Neuropathic Painkiller ZTlido In The Middle East And North Africa ...

Sorrento Therapeutics, Inc.'s Net Worth

1mon ago, source: Benzinga.com

Who is Sorrento Therapeutics, Inc.? Sorrento Therapeutics, Inc. has an estimated net worth of $5.73 Million. This is based on reported shares across multiple companies, which include Celularity ...

Sorrento Issues Supplement to its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock

1y ago, source: Yahoo Finance

SAN DIEGO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today posted a supplement to its previously issued “Frequently Asked Questions” document ...

Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session

12mon ago, source: Hosted on MSN

Scilex Holding, a majority-owned subsidiary of Sorrento Therapeutics, Inc, entered a master distributor agreement with AD Ports Logistics (ADPL). Bed Bath & Beyond Inc. (NASDAQ: BBBY) fell 23% to ...

Sorrento Therapeutics Inc. (SRNEQ)

1y ago, source: Nasdaq

Call and put options are quoted in a table called a chain sheet. The chain sheet shows the price, volume and open interest for each option strike price and expiration month. Nasdaq provides call ...

Sorrento Therapeutics Inc. (SRNEQ)

1y ago, source: Nasdaq

Nasdaq provides company’s SEC filings, which are financial statements and reports filed electronically with the U.S. Securities and Exchange Commission (SEC) by Quotemedia. The SEC ...

SRNEQ Sorrento Therapeutics, Inc.

1mon ago, source: Seeking Alpha

The security has traded for less than one year There is no Wall Street analyst coverage The security is a closed-end fund or a mortgage REIT The security is listed on a non-US exchange The ...

Sorrento Therapeutics Inc (SRNEQ)

1mon ago, source: Investing

Investing.com - Sorrento Therape reported on Friday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations. Sorrento Therape announced... H.C. Wainwright ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...